164 related articles for article (PubMed ID: 34820552)
21. Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs.
Bhutia YD; Babu E; Ramachandran S; Ganapathy V
Cancer Res; 2015 May; 75(9):1782-8. PubMed ID: 25855379
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humans.
Gupta N; Miyauchi S; Martindale RG; Herdman AV; Podolsky R; Miyake K; Mager S; Prasad PD; Ganapathy ME; Ganapathy V
Biochim Biophys Acta; 2005 Jun; 1741(1-2):215-23. PubMed ID: 15905073
[TBL] [Abstract][Full Text] [Related]
23. Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14.
Dejure FR; Butzer J; Lindemann RK; Mardin BR
Oncotarget; 2020 Dec; 11(48):4490-4503. PubMed ID: 33400734
[TBL] [Abstract][Full Text] [Related]
24. Flagellin From
Barilli A; Visigalli R; Ferrari F; Borsani G; Dall'Asta V; Rotoli BM
Front Immunol; 2021; 12():641563. PubMed ID: 33841424
[TBL] [Abstract][Full Text] [Related]
25. L-type amino acid transporter 1, LAT1, in growth hormone-producing pituitary tumor cells.
Satou M; Wang J; Nakano-Tateno T; Teramachi M; Suzuki T; Hayashi K; Lamothe S; Hao Y; Kurata H; Sugimoto H; Chik C; Tateno T
Mol Cell Endocrinol; 2020 Sep; 515():110868. PubMed ID: 32579901
[TBL] [Abstract][Full Text] [Related]
26. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
Ganapathy V; Thangaraju M; Prasad PD
Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
[TBL] [Abstract][Full Text] [Related]
27. Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth.
Bothwell PJ; Kron CD; Wittke EF; Czerniak BN; Bode BP
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30029480
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells.
Vazquez-Martin A; Colomer R; Brunet J; Lupu R; Menendez JA
Cell Prolif; 2008 Feb; 41(1):59-85. PubMed ID: 18211286
[TBL] [Abstract][Full Text] [Related]
29. Targeting L-type amino acid transporter 1 in innate and adaptive T cells efficiently controls skin inflammation.
Cibrian D; Castillo-González R; Fernández-Gallego N; de la Fuente H; Jorge I; Saiz ML; Punzón C; Ramírez-Huesca M; Vicente-Manzanares M; Fresno M; Daudén E; Fraga-Fernandez J; Vazquez J; Aragonés J; Sánchez-Madrid F
J Allergy Clin Immunol; 2020 Jan; 145(1):199-214.e11. PubMed ID: 31605740
[TBL] [Abstract][Full Text] [Related]
30. Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor.
Okanishi H; Ohgaki R; Okuda S; Endou H; Kanai Y
Cancer Sci; 2021 Feb; 112(2):871-883. PubMed ID: 33264461
[TBL] [Abstract][Full Text] [Related]
31. ATB
Luo Q; Yang B; Tao W; Li J; Kou L; Lian H; Che X; He Z; Sun J
Biomater Sci; 2017 Jan; 5(2):295-304. PubMed ID: 27991616
[TBL] [Abstract][Full Text] [Related]
32. The Na
Sikder MOF; Yang S; Ganapathy V; Bhutia YD
AAPS J; 2017 Dec; 20(1):12. PubMed ID: 29204754
[TBL] [Abstract][Full Text] [Related]
33. Imaging tumour ATB0,+ transport activity by PET with the cationic amino acid O-2((2-[18F]fluoroethyl)methyl-amino)ethyltyrosine.
Müller A; Chiotellis A; Keller C; Ametamey SM; Schibli R; Mu L; Krämer SD
Mol Imaging Biol; 2014 Jun; 16(3):412-20. PubMed ID: 24307544
[TBL] [Abstract][Full Text] [Related]
34. Hemocompatible LAT1-inhibitor can induce apoptosis in cancer cells without affecting brain amino acid homeostasis.
Markowicz-Piasecka M; Huttunen J; Montaser A; Huttunen KM
Apoptosis; 2020 Jun; 25(5-6):426-440. PubMed ID: 32405891
[TBL] [Abstract][Full Text] [Related]
35. JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells.
Choi DW; Kim DK; Kanai Y; Wempe MF; Endou H; Kim JK
Korean J Physiol Pharmacol; 2017 Nov; 21(6):599-607. PubMed ID: 29200902
[TBL] [Abstract][Full Text] [Related]
36. Mitochondria Targeting and Destabilizing Hyaluronic Acid Derivative-Based Nanoparticles for the Delivery of Lapatinib to Triple-Negative Breast Cancer.
Lee SY; Cho HJ
Biomacromolecules; 2019 Feb; 20(2):835-845. PubMed ID: 30566834
[TBL] [Abstract][Full Text] [Related]
37. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
[TBL] [Abstract][Full Text] [Related]
38. The L-Type Amino Acid Transporter LAT1-An Emerging Target in Cancer.
Häfliger P; Charles RP
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31100853
[TBL] [Abstract][Full Text] [Related]
39. Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells.
Vazquez-Martin A; Oliveras-Ferraros C; Colomer R; Brunet J; Menendez JA
Ann Oncol; 2008 Jun; 19(6):1097-109. PubMed ID: 18283037
[TBL] [Abstract][Full Text] [Related]
40. Expression of L-type amino acid transporter 1 as a molecular target for prognostic and therapeutic indicators in bladder carcinoma.
Maimaiti M; Sakamoto S; Yamada Y; Sugiura M; Rii J; Takeuchi N; Imamura Y; Furihata T; Ando K; Higuchi K; Xu M; Sazuka T; Nakamura K; Kaneda A; Kanai Y; Kyprianou N; Ikehara Y; Anzai N; Ichikawa T
Sci Rep; 2020 Jan; 10(1):1292. PubMed ID: 31992742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
